Erratum to: Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B (Journal of Medical Virology, (2013), 85, 5, (789-798), 10.1002/jmv.23540);Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B

Journal of Medical Virology

Volumn 85, Issue 5, 2013, Pages 789-798

  Arataki, Keiko ^a,b,c   Hayes, C Nelson ^a,b   Akamatsu, Sakura ^a,b   Akiyama, Rie ^a,b   Abe, Hiromi ^a,b   Tsuge, Masataka ^a   Miki, Daiki ^a,b   Ochi, Hidenori ^a,b   Hiraga, Nobuhiko ^a,b   Imamura, Michio ^a,b   Takahashi, Shoichi ^a,b   Aikata, Hiroshi ^a   Kawaoka, Tomokazu ^a,b   Kawakami, Hiroiku ^a,b   Ohishi, Waka ^a,d   Chayama, Kazuaki ^a,b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b RIKEN   (Japan)

^c TSUCHIYA GENERAL HOSPITAL   (Japan)

^d RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

HBsAg; Histological activity; Inflammation; MicroRNA

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; MICRORNA 122; MICRORNA 22;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

EID: 84875679628     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23913     Document Type: Erratum

References (31)

1. Bala S, Marcos M, Szabo G. 2009. Emerging role of microRNAs in liver diseases. World J Gastroenterol 15:5633-5640.
2. Beasley RP, Hwang LY, Lin CC, Chien CS. 1981. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 2:1129-1133.
3. Blumberg BS, Alter HJ, Visnich S. 1965. A "New" antigen in leukemia sera. JAMA 191:541-546.
4. Chen Y, Shen A, Rider PJ, Yu Y, Wu K, Mu Y, Hao Q, Liu Y, Gong H, Zhu Y, Liu F, Wu J. 2011. A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication. Faseb J 25:4511-4521.
5. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. 1994. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19:1513-1520.
6. Fields BN, Knipe DM, Howley PM. 2007. Fields virology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins.
7. Gao P, Wong CC, Tung EK, Lee JM, Wong CM, Ng IO. 2011. Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis. J Hepatol 54:1177-1184.
8. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, Qin L, Wu X, Zheng Y, Yang Y, Tian W, Zhang Q, Wang C, Zhang Q, Zhuang S-M, Zheng L, Liang A, Tao W, Cao X. 2011. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19:232-243.
9. Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, Qin LX, Man K, Lo CM, Lee J, Ng IO, Fan J, Tang ZY, Sun HC, Wang XW. 2009. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 361:1437-1447.
10. Ji F, Yang B, Peng X, Ding H, You H, Tien P. 2011. Circulating microRNAs in hepatitis B virus-infected patients. J Viral Hepat 18:e242-e251.
11. Jiang R, Deng L, Zhao L, Li X, Zhang F, Xia Y, Gao Y, Wang X, Sun B. 2011. miR-22 promotes HBV-related hepatocellular carcinoma development in males. Clin Cancer Res 17:5593-5603.
12. Kim YJ, Jung JK, Lee SY, Jang KL. 2010. Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16(INK4a) expression via DNA methylation. Cancer Lett 288:226-235.
13. Koturbash I, Melnyk S, James SJ, Beland FA, Pogribny IP. 2011. Role of epigenetic and miR-22 and miR-29b alterations in the downregulation of Mat1a and Mthfr genes in early preneoplastic livers in rats induced by 2-acetylaminofluorene. Mol Carcinog DOI: 10.1002/mc.21861. [Epub ahead of print].
14. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, Lin C, Socci ND, Hermida L, Fulci V, Chiaretti S, Foa R, Schliwka J, Fuchs U, Novosel A, Muller RU, Schermer B, Bissels U, Inman J, Phan Q, Chien M, Weir DB, Choksi R, De Vita G, Frezzetti D, Trompeter HI, Hornung V, Teng G, Hartmann G, Palkovits M, Di Lauro R, Wernet P, Macino G, Rogler CE, Nagle JW, Ju J, Papavasiliou FN, Benzing T, Lichter P, Tam W, Brownstein MJ, Bosio A, Borkhardt A, Russo JJ, Sander C, Zavolan M, Tuschl T. 2007. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129:1401-1414.
15. Lavanchy D. 2004. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11:97-107.
16. Liu L, Jiang Y, Zhang H, Greenlee AR, Yu R, Yang Q. 2010. miR-22 functions as a micro-oncogene in transformed human bronchial epithelial cells induced by anti-benzo[a]pyrene-7, 8-diol-9, 10-epoxide. Toxicol In Vitro 24:1168-1175.
17. Mariana L-Q, Reinhard R, Abdullah Y, Jutta M, Winfried L, Thomas T. 2002. Identification of tissue-specific microRNAs from mouse. Curr Biol 12:735-739.
18. McMahon BJ. 2009. The natural history of chronic hepatitis B virus infection. Hepatology 49:S45-S55.
19. Mizuguchi Y, Mishima T, Yokomuro S, Arima Y, Kawahigashi Y, Shigehara K, Kanda T, Yoshida H, Uchida E, Tajiri T, Takizawa T. 2011. Sequencing and bioinformatics-based analyses of the microRNA transcriptome in hepatitis B-related hepatocellular carcinoma. PLoS ONE 6:e15304.
20. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, Shimotohno K. 2006. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25:2537-2545.
21. Pandey DP, Picard D. 2009. miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA. Mol Cell Biol 29:3783-3790.
22. Qi P, Cheng SQ, Wang H, Li N, Chen YF, Gao CF. 2011. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS ONE 6:e28486.
23. Qiu L, Fan H, Jin W, Zhao B, Wang Y, Ju Y, Chen L, Chen Y, Duan Z, Meng S. 2010. miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV. Biochem Biophys Res Commun 398:771-777.
24. Tsuchiya N, Izumiya M, Ogata-Kawata H, Okamoto K, Fujiwara Y, Nakai M, Okabe A, Schetter AJ, Bowman ED, Midorikawa Y, Sugiyama Y, Aburatani H, Harris CC, Nakagama H. 2011. Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21. Cancer Res 71:4628-4639.
25. Ura S, Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Sunakozaka H, Sakai Y, Horimoto K, Kaneko S. 2009. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 49:1098-1112.
26. Waidmann O, Bihrer V, Pleli T, Farnik H, Berger A, Zeuzem S, Kronenberger B, Piiper A. 2012. Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection. J Viral Hepat 19:e58-e65.
27. Wang S, Qiu L, Yan X, Jin W, Wang Y, Chen L, Wu E, Ye X, Gao GF, Wang F, Chen Y, Duan Z, Meng S. 2011. Loss of miR-122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G1 modulated P53 activity. Hepatology 55:730-741.
28. Xu J, Wu C, Che X, Wang L, Yu D, Zhang T, Huang L, Li H, Tan W, Wang C, Lin D. 2011a. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 50:136-142.
29. Xu D, Takeshita F, Hino Y, Fukunaga S, Kudo Y, Tamaki A, Matsunaga J, Takahashi RU, Takata T, Shimamoto A, Ochiya T, Tahara H. 2011b. miR-22 represses cancer progression by inducing cellular senescence. J Cell Biol 193:409-424.
30. Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y, Guo H, Fei M, Sun S. 2010. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 56:1830-1838.
31. Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z, Wang JF, Zhang Z, Lu S, Huang X, Wang Z, Qiu S, Wang X, Yang G, Sun H, Tang Z, Wu Y, Zhu H, Fan J. 2011. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 29:4781-4788.